Loading clinical trials...
Loading clinical trials...
In the last years, botulinum toxin type A (onab/A) has been increasingly used as a treatment option for overactive bladder symptoms in patients affected by either neurogenic and idiopathic detrusor ov...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Of Perugia
Collaborators
NCT06212661 · Overactive Bladder, Bladder Pain Syndrome, and more
NCT01781117 · Benign Prostatic Hypertrophy With Outflow Obstruction, Overactive Detrusor
NCT01837654 · Overactive Detrusor
University of Perugia, Dept. of Urology and Andrology
Perugia, Italy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions